Abstract
Weight gain during short-term clozapine treatment is well known. It has been reported to correlate with treatment response. The long-term course of weight gain during clozapine treatment has not been well studied. In a sample of 73 mostly schizophrenic patients, we investigated weight change during short- and long-term treatment (up to 90 months) with clozapine and its correlation with treatment response. The patients showed significant weight increase during the first 12 weeks, reaching a significant weight gain by the second week. Responders and non-responders by week 6 or 12, respectively, did not differ in regard to weight gain by those respective weeks. Also, weight gain during the first 8 weeks was not particularly correlated with treatment response after 6 months. Survival analysis revealed that 80% of the patients gained at least 10% weight and about a third of the patients showed an increase of 20% or more. More than half the patients became overweight by 20% or more. The results indicate that weight gain during clozapine treatment is a significant clinical problem with potentially adverse effects to patients. Research into its treatment is needed.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Umbricht, D., Pollack, S., Lieberman, J. et al. Clozapine And Weight Gain - Association With Clinical Response And Long-Term Course. Neuropsychopharmacol 11, 288 (1994). https://doi.org/10.1038/sj.npp.1380224
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.npp.1380224